Modified ice study: A phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer-Reference-Cited by-同舟云学术

Modified ice study: A phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer

Published:1998-08 Issue:2 Volume:21 Page:115-126
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Shevlin P.M,Muers M.F,Peake M.D,Hosker H.S.R,Stead M.L,Poulter K.M,Brown J.M

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference27 articles.

1. Carcinoma of bronchus in the Yorkshire Region of England 1974–1990: trends since 1984;Connolly;Eur Respir J,1997

2. Medical Research Council Lung Cancer Working Party. Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small cell-lung cancer. Respir Med 1989;83:51–8.

3. An overview of prognostic factors in small cell lung cancer;Rawson;Br J Cancer,1990

4. Report of a Working Group to the Standing Medical Advisory Committee, Department of Health (1994). Management of Lung Cancer. Current clinical practices.

5. Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for ‘limited’ stage small cell carcinoma of the bronchus;Thatcher;Br J Cancer,1989

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising effects of 3rd line cyclophosphamide, adriamycin and vincristine (CAV) and 4th line ifosfamide and carboplatin chemotherapy in refractory small cell lung cancer;Thoracic Cancer;2015-01-27

2. Standard versus Dose-Intensified Chemotherapy with Sequential Reinfusion of Hematopoietic Progenitor Cells in Small Cell Lung Cancer Patients with Favorable Prognosis;Journal of Thoracic Oncology;2007-01

3. The science of quality-of-life measurement in lung cancer;Outcomes Assessment in Cancer;2004-12-23

4. Outpatient Intensive Chemotherapy for Small Cell Lung Cancer: Five Years Experience of Modified ‘ICE’ Ifosfamide Carboplatin and Etoposide;Clinical Oncology;2002-10

5. A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer;British Journal of Cancer;2001